DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "drugmaker Pfizer"


2 mentions found


☆ RSV vaccine race heats up with highly effective GSK shot
  + stars: | 2022-10-13 | by ( Natalie Grover | ) www.reuters.com   time to read: +3 min
LONDON, Oct 13 (Reuters) - Data unveiled on Thursday showed GSK's (GSK.L) respiratory syncytial virus (RSV) vaccine was 82.6% effective in a keenly watched late-stage study involving older adults. The company is a key player in the race to develop a safe and effective RSV vaccine, which, if approved, is expected to generate billions in sales for its maker. If approved, Jefferies analysts have forecast $2.5 billion in global RSV vaccine peak sales in older adults for GSK. U.S. drugmaker Pfizer (PFE.N) in August disclosed positive Phase III data on its rival RSV vaccine in older adults. In trial participants with pre-existing conditions, the GSK vaccine was shown to be 94.6% effective, while in adults aged 70 to 79 it was 93.8% effective, the company said.
☆ Sen. David Perdue is raising big campaign money with DC lobbyists. He also traded stock shares of several of the companies the lobbyists represent.
  + stars: | 2020-12-09 | by ( Dave Levinthal | ) www.businessinsider.com   time to read: +8 min
The senator this year has bought or sold these companies' stock shares, according to an Insider analysis of federal records. The senator's stock trades have become a highly politicized issue, with Ossoff and Democratic allies spending millions of dollars on ads highlighting the controversy. Perdue sold hundreds of thousands of dollars worth of these companies' stock shares during 2020, an Insider analysis of Senate stock trade disclosure records indicates. The Perdue campaign and the fundraiser coordinator, Alice Perry of The Elevated Group, did not return several requests for comment. The Ossoff campaign declined to comment.
<< prev 1 next >>
Total: 2